financetom
Business
financetom
/
Business
/
Bloomin' Brands Reports Q4 Sales Decline: 'Not Representative Of Our Potential,' Says CEO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bloomin' Brands Reports Q4 Sales Decline: 'Not Representative Of Our Potential,' Says CEO
Feb 26, 2025 6:36 AM

Bloomin’ Brands Inc shares are trading lower in premarket on Wednesday.

The company reported a fourth-quarter FY24 sales decline of 9.3% year-on-year to $972 million, missing the analyst consensus estimate of $1.08 billion.

Combined U.S. comparable restaurant sales fell 1.1% during the quarter, with a 1.8% decline in Outback Steakhouse and a 3% climb in Fleming's Prime Steakhouse & Wine Bar.

Restaurant sales decreased 9.2% Y/Y to $952 million, while Franchise and other revenues declined 13.8% to $19.9 million.

U.S. segment revenue slipped 8.6% Y/Y to $952.5 million, and the International segment decreased 5.4% Y/Y to $9.9 million.

Total cost and expenses for the quarter dropped 6.5% Y/Y to $955.8 million.

Restaurant-level operating margin contracted by 350 basis points to 12.4%. The operating margin was 1.7%, and the operating income was $16.2 million.

Also Read: Tesla Acquires German Tech Firm Manz Assets Amid Insolvency

The company held $70.1 million in cash and equivalents as of Dec. 29, 2024. The company had a total debt of $1.03 million.

Adjusted EPS of $0.38 beat the consensus estimate of $0.36.

On Feb. 12, 2025, the Board of Directors declared a quarterly cash dividend of $0.15 per share, payable on March 26, to stockholders of record at the close of business on March 11.

“I am also aware that our current results are not what we expect and are not representative of our potential. We are making changes to address our near-term execution as well as drive sustainable sales and profit growth. Our guidance for the first quarter and full year is reflective of where we are and our go-forward short term performance,” said CEO Mike Spanos.

Outlook: Bloomin’ Brands sees FY25 U.S. comparable restaurant sales of (2%) – Flat. The company sees FY25 adjusted EPS of $1.20 to $1.40 versus the estimate of $1.77.

Bloomin’ sees first-quarter U.S. comparable restaurant sales of (1.5%) – (0.5%). It expects first-quarter adjusted EPS of $0.55 – $0.60, against the consensus of $0.68.

Price Action: BLMN shares are trading lower by 5% at $11.30 in premarket at last check Wednesday.

Read Next:

Unilever CEO Hein Schumacher To Step Down, Fernando Fernandez To Take Over

Image created using artificial intelligence via Midjourney.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Coterra Energy Insider Sold Shares Worth $2,653,855, According to a Recent SEC Filing
Coterra Energy Insider Sold Shares Worth $2,653,855, According to a Recent SEC Filing
May 26, 2025
04:51 PM EDT, 05/09/2025 (MT Newswires) -- Stephen P Bell, Executive Vice President, Business Development, on May 08, 2025, sold 115,385 shares in Coterra Energy ( CTRA ) for $2,653,855. Following the Form 4 filing with the SEC, Bell has control over a total of 329,652 common shares of the company, with 329,652 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/858470/000085847025000141/xslF345X05/wk-form4_1746823693.xml ...
Bain Capital to buy PCI Pharma at $10 billion valuation, Bloomberg News reports
Bain Capital to buy PCI Pharma at $10 billion valuation, Bloomberg News reports
May 26, 2025
(Reuters) -Bain Capital is in talks to buy contract drug manufacturer PCI Pharma Services at a valuation of $10 billion, Bloomberg News reported on Friday, citing people familiar with the matter. The buyout firm is in discussions with PCI's backers - Kohlberg & Co, Mubadala Investment Co and Partners Group Holding AG - about a deal for a majority stake...
Cdw Insider Sold Shares Worth $7,423,293, According to a Recent SEC Filing
Cdw Insider Sold Shares Worth $7,423,293, According to a Recent SEC Filing
May 26, 2025
04:56 PM EDT, 05/09/2025 (MT Newswires) -- Christine A Leahy, Director, Chair, President and Chief Executive Officer on May 08, 2025, sold 40,917 shares in Cdw (CDW) for $7,423,293. Following the Form 4 filing with the SEC, Leahy has control over a total of 162,181 common shares of the company, with 144,931 shares held directly and 17,250 controlled indirectly. SEC...
Copyright 2023-2026 - www.financetom.com All Rights Reserved